Related Experiment Videos
Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours
J C Nicholson1, F M Ross, J A Kohler
1Wessex Regional Genetics Laboratory, Salisbury, Wiltshire, UK.
British Journal of Cancer
|July 29, 1999
Summary
Chromosomal imbalances in central nervous system primitive neuroectodermal tumors (PNETs) correlate with tumor site and histology. Medulloblastomas show specific genetic alterations linked to their subtypes and clinical outcomes.
Area of Science:
- Neuro-oncology
- Genetics
- Cancer research
Background:
- Central nervous system primitive neuroectodermal tumors (PNETs) are aggressive brain tumors.
- Understanding the genetic basis of PNETs is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate if chromosomal imbalances in PNETs are associated with their location and histological subtypes.
- To identify specific genetic alterations linked to different PNET variants.
Main Methods:
- Comparative genomic hybridization (CGH) was used to analyze chromosomal imbalances in 37 PNET cases.
- Immunophenotyping was performed using antibodies for neuroglial, mesenchymal, and epithelial markers.
- Tumor samples included cerebral PNETs and medulloblastomas (classic and nodular/desmoplastic subtypes).
Main Results:
- Chromosomal imbalances were found in 90% of medulloblastomas, with significant associations between tumor variants and genetic abnormalities.
- Isochromosome 17q aberrations were present in 26% of medulloblastomas, predominantly in classic variants.
- Loss of 9q was observed in 19% of cases, mainly in nodular/desmoplastic subtypes, while loss of chromosome 22 occurred in 13% of classic medulloblastomas in young patients with poor outcomes.
- Cerebral PNETs exhibited distinct imbalance patterns, including losses of 3p12.3-p14, with no chromosome 17 abnormalities.
Conclusions:
- Chromosomal imbalances in PNETs are site- and histology-dependent.
- Specific genetic alterations, such as i(17q), 9q loss, and 22 loss, are associated with distinct medulloblastoma subtypes and clinical outcomes.
- Cerebral PNETs have unique genetic profiles compared to medulloblastomas.